Available from: Rentzeperi E, Pegiou S, Koufakis T, et al Sex differences in response to treatment with glucagon-like peptide 1 receptor agonists: opportunities for a tailored approach to diabetes and obesity care
doi: 10.1038/ncomms8735 200
Tirzepatide: Even greater, with average weight loss of 15-22% depending on dose
He further identified pancreatic abscesses, splenic vein thrombosis, and pancreatic pseudocysts as related complications of the disease
As part of their study, researchers also looked at dipeptidyl peptidase-4 (DPP-4) inhibitors and pioglitazone, two other drugs used to treat type 2 diabetes
The medication is designed to fit into your routine, and many individuals are able to work, exercise, and carry out normal tasks without major interruptions